WN22018 - Use of RO5313534 as add on to donepezil in Alzheimer's

• Research type

  Research Study

• Full title

  A dose ranging, randomized, double blind, parallel-group placebo-controlled multi-center study of RO5313534 used as add-on to donepezil treatment in patients with mild to moderate symptoms of Alzheimer’s Disease

• IRAS ID

  13611

• Contact name

  David Wilkinson

• Contact email

  david.wilkinson@wht.nhs.uk

• Sponsor organisation

  F Hoffman-La Roche Ltd

• Eudract number

  2008-004012-13

• ISRCTN Number

  n/a

• Research summary

  Research Summary not published at request of researcher

• REC name

  South Central - Hampshire B Research Ethics Committee

• REC reference

  09/H0504/31

• Date of REC Opinion

  3 Apr 2009

• REC opinion

  Further Information Favourable Opinion